Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies

NCT03733496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2023-12-22

No results posted yet for this study

Summary

An extension study for participants who have completed a prior VY-AADC01 clinical study

Conditions

Sponsors & Collaborators

  • Voyager Therapeutics

    collaborator INDUSTRY
  • Neurocrine Biosciences

    lead INDUSTRY

Principal Investigators

  • Clinical Development Lead · Neurocrine Biosciences

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-24
Primary Completion
2023-07-18
Completion
2023-07-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03733496 on ClinicalTrials.gov